Clinical Trial Update: A Study to Assess Efficacy and Safety of Efgartigimod PH20 SC in Adults With Ocular Myasthenia Gravis [Phase 3]

View source ↗

Summary

Phase 3 clinical trial update assessing the efficacy and safety of Efgartigimod PH20 SC in adults with ocular myasthenia gravis; the study is currently active b…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Ocular Myasthenia Gravis

Drugs mentioned

• Efgartigimod PH20 SC (efgartigimod alfa)

Snippet

Sponsor: argenx | Conditions: Myasthenia Gravis, Ocular | Phase 3 | Status: ACTIVE_NOT_RECRUITING